Old world cutaneous leishmaniasis in Iran: clinical variants and treatments

被引:37
|
作者
Firooz, Alireza [1 ]
Mortazavi, Hossein [2 ]
Khamesipour, Ali [1 ]
Ghiasi, Maryam [2 ]
Abedini, Robabeh [2 ]
Balighi, Kamran [2 ]
Esmaili, Nafiseh [2 ]
Nassiri-Kashani, Mansour [1 ]
Eskandari, S. Ebrahim [1 ]
Mohebali, Mehdi [3 ]
Mohammadi, Akram Mir Amin [1 ]
Dowlati, Yahya [1 ]
机构
[1] Univ Tehran Med Sci, Ctr Res & Training Skin Dis & Leprosy, Tehran, Iran
[2] Univ Tehran Med Sci, Razi Hosp, Dept Dermatol, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Parasitol & Mycol, Tehran, Iran
关键词
Old World cutaneous leishmaniasis; clinical variants; treatment; pentavalent antimonial; INTRALESIONAL MEGLUMINE ANTIMONIATE; VISCERAL LEISHMANIASIS; AMPHOTERICIN-B; DOUBLE-BLIND; DIAGNOSIS; COMBINATION; EFFICACY; LYMPHADENITIS; MILTEFOSINE; CRYOTHERAPY;
D O I
10.1080/09546634.2019.1704214
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Old World cutaneous leishmaniasis (OWCL) is endemic in Iran and most cases of cutaneous leishmaniasis (CL) are caused by Leishmania major, and then Leishmania tropica, and rarely by Leishmania infantum. Objective: We aimed to describe clinical variants of OWCL and their treatments. Method: Through literature search in PubMed, Scopus and Embase and google scholar, we have found articles about variant clinical pictures of OWCL and their treatments. Results: The following clinical variants of OWCL namely; localized forms, zosteriform, erysipeloid, eczematoid, warty, localized Leishmania lymphadenitis, sporotrichoid, hyperkeratotic, impetiginized, mucosal involvement in CL, lupoid leishmaniasis, chronic lesions due to leishmanization, disseminated cutaneous leishmaniasis, reactivation of CL after transplantation and coexistence of CL with other diseases, are reported from Iran. The mainstay of therapy remains pentavalent antimonial compounds and cryotherapy is an adjuvant to therapy. Treatment with antifungal agents, miltefosine, amphotericin B and herbal extract such as ZH-E have also been used. Treatment of CL in chronic cases and in immunosuppressed patients is difficult and relapse may occur. Conclusion: In clinical variants of CL with long duration and multiple lesions, systemic pentavalent antimonial compounds are first step of therapy. In case of incomplete response or resistant to classic treatment, combination therapy is indicated.
引用
收藏
页码:673 / 683
页数:11
相关论文
共 50 条
  • [21] Azithromycin is not effective in the treatment of old world cutaneous leishmaniasis
    Momeni, Ali Z.
    Shafiei, Ali
    Emamjoeh, Morteza
    Aminjavaheri, Malihalsadat
    Momeni, Amir
    EUROPEAN JOURNAL OF DERMATOLOGY, 2006, 16 (06) : 701 - 702
  • [22] Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients
    Dorlo, Thomas P. C.
    van Thiel, Pieter P. A. M.
    Huitema, Alwin D. R.
    Keizer, Ron J.
    de Vries, Henry J. C.
    Beijnen, Jos H.
    de Vries, Peter J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (08) : 2855 - 2860
  • [23] Designing and Reporting Clinical Trials on Treatments for Cutaneous Leishmaniasis
    Gonzalez, Urba
    Pinart, Mariona
    Reveiz, Ludovic
    Rengifo-Pardo, Monica
    Tweed, Jack
    Macaya, Antonio
    Alvar, Jorge
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (04) : 409 - 419
  • [24] Oriental Sore (Old-World Cutaneous Leishmaniasis)
    Schueuermann, Monica
    Kunz, Manfred
    Luebbert, Christoph
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2017, 114 (44): : 754 - 754
  • [25] Clinical, microscopic and molecular presentation in pediatric versus adult old world cutaneous Leishmaniasis
    Dunya, Gabriel
    Loya, Asif
    Taraif, Suad
    Houreih, Mohammad Adib
    Khalifeh, Ibrahim
    PEDIATRIC DERMATOLOGY, 2020, 37 (04) : 656 - 660
  • [26] Systematic review of New World cutaneous leishmaniasis: few points to be applied to Old World leishmaniasis
    Tuon, Felipe Francisco
    Amato, Valdir Sabbaga
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (02) : 201 - 202
  • [27] Old World cutaneous leishmaniasis challenges in Morocco, Algeria, Tunisia and Iran (MATI): a collaborative attempt to combat the disease
    Bahrami, Fariborz
    Spath, Gerald F.
    Rafati, Sima
    EXPERT REVIEW OF VACCINES, 2017, 16 (05) : 415 - 417
  • [28] Clinical Response with intralesional Amphotericin B in the treatment of old world cutaneous leishmaniasis: a preliminary report
    Mushtaq, Sabha
    Dogra, Devraj
    Dogra, Naina
    DERMATOLOGIC THERAPY, 2016, 29 (06) : 398 - 405
  • [29] Old world cutaneous leishmaniasis infection in children: a case series
    Jones, J
    Bowling, J
    Watson, J
    Vega-Lopez, F
    White, J
    Higgins, E
    ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 (05) : 530 - 531
  • [30] Azithromycin, ineffective in the treatment of old-world cutaneous leishmaniasis
    Daoud, Saleh
    Boushi, Lamis
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (09) : 1126 - 1128